Women's Hormonal Health: Why Investors Are Paying Attention

​Women’s hormonal health is moving from a long-neglected clinical area into a structurally investable segment of healthcare. 

​Driven by advances in diagnostics, clearer links to chronic disease and longevity, and a rapidly expanding midlife patient population, this space is beginning to attract serious capital not as a niche, but as healthcare infrastructure with repeat demand and long time horizons.

​This investor-focused fireside conversation will examine where the science is mature and how capital is being deployed today. We will explore what has changed since the first wave of femtech, what investors are underwriting now, and which business models are proving scalable and defensible.

​Designed for investors, capital allocators, and anyone interested in the future of women's health, this session offers a clear-eyed view of women’s hormonal health as an emerging investment frontier separating signal from noise, and opportunity from hype.

​​​Spaces are limited, so RSVP today to secure your spot.